These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 574911)

  • 1. Mechanism of action of antiestrogens and androgens on the estrogen receptor.
    Rochefort H; Capony F; Garcia M
    J Steroid Biochem; 1979; 11(5-6):1635-8. PubMed ID: 574911
    [No Abstract]   [Full Text] [Related]  

  • 2. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
    Rochefort H; Capony F
    Biochem Biophys Res Commun; 1977 Mar; 75(2):277-85. PubMed ID: 557979
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of LN 1643 (a triphenylbromoethylene antiestrogen): probable mediation by the estrogen receptor and high affinity metabolite.
    Borgna JL; Coezy E; Rochefort H
    Biochem Pharmacol; 1982 Oct; 31(20):3187-91. PubMed ID: 7150347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
    Rorke EA; Katzenellenbogen BS
    Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological potency and uterine estrogen receptor interactions of the metabolites of the antiestrogens CI628 and U23,469.
    Hayes JR; Rorke EA; Robertson DW; Katzenellenbogen BS; Katzenellenbogen JA
    Endocrinology; 1981 Jan; 108(1):164-72. PubMed ID: 7007017
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor.
    Rochefort H; Garcia M; Borgna JL
    Biochem Biophys Res Commun; 1979 May; 88(2):351-7. PubMed ID: 465043
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of androgens with oestradiol-17beta receptor proteins in DMBA-induced mammary tumours--a possible oncolytic mechanism.
    Nicholson RI; Davies P; Griffiths K
    Eur J Cancer (1965); 1978 Apr; 14(4):439-45. PubMed ID: 417921
    [No Abstract]   [Full Text] [Related]  

  • 12. Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor.
    Sutherland RL; Watts CK; Ruenitz PC
    Biochem Biophys Res Commun; 1986 Oct; 140(2):523-9. PubMed ID: 3778464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple forms of nuclear estrogen receptor in the immature rat uterus after in vitro exchange with [3H]estradiol or [3H] antiestrogens.
    Attardi B
    Mol Cell Endocrinol; 1983 Feb; 29(2):159-67. PubMed ID: 6832469
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of estrogen and antiestrogen competition for hypothalamic cytosol estrogen receptors. Evidence for noncompetitive ligand-receptor interactions.
    Etgen AM; Whalen RE
    J Recept Res; 1981-1982; 2(5-6):531-53. PubMed ID: 7349316
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and biological responses of antiestrogens in the fetal and newborn uteri of guinea-pig.
    Gulino A; Pasqualini JR
    J Steroid Biochem; 1981 Dec; 15():361-7. PubMed ID: 7339264
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
    Jordan VC
    Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.